Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05056064
Other study ID # 63222
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2021
Est. completion date May 31, 2022

Study information

Verified date November 2021
Source Rajavithi Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Efficacy of swallowing function after early postoperative oral exercise among patient with oral cavity cancer underwent flap reconstruction: A randomized controlled trial


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date May 31, 2022
Est. primary completion date May 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patient with CA tongue and tumor size 2 cm Exclusion Criteria: - previous treatment - history of head and neck cancer

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oral exercise
exercise remain tongue

Locations

Country Name City State
Thailand Rajavithi Hospital Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Rajavithi Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy swallowing function Efficacy of swallowing function evaluate by Penetration-Aspiration scale by Rosenbek, this questionnaire classify patient for 8 score, from no entry of material into the larynx or trachea to material enters the trachea with no attempt to clear 1 year
See also
  Status Clinical Trial Phase
Completed NCT01695122 - Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 2
Recruiting NCT05793151 - Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy N/A
Recruiting NCT01958762 - Screening for Cancers in the Oral CAvity N/A
Recruiting NCT05429099 - Mandibular Reconstruction Preplanning (ViPMR) Phase 2/Phase 3
Recruiting NCT05757817 - Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae N/A
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT04809324 - Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers N/A
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Terminated NCT03555721 - CytID Analysis of Oral Lesions
Completed NCT01116843 - Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment Phase 1/Phase 2
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Active, not recruiting NCT03082534 - Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Phase 2
Completed NCT03096808 - Adaptive Radiotherapy for Head and Neck Cancer Phase 2
Completed NCT00359645 - Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population Phase 3
Completed NCT02412241 - Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients N/A
Terminated NCT00934739 - A Study of High-Risk Oral Cavity Cancer Phase 2/Phase 3
Recruiting NCT05337631 - Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Recruiting NCT05927220 - WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Recruiting NCT05369234 - Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis Phase 3
Recruiting NCT04330781 - Radiotherapy of Head and Neck Cancer Using an Intraoral Stent Phase 2